S

Silverback Therapeutics Inc
NASDAQ:SBTX

Watchlist Manager
Silverback Therapeutics Inc
NASDAQ:SBTX
Watchlist
Price: 5.87 USD 1.03% Market Closed
Updated: May 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

281.4m
Assets
8.5m
Liabilities
272.9m
Equity

Balance Sheet Decomposition
Silverback Therapeutics Inc

281.4m
Assets
8.5m
Liabilities
281.4m
Assets
8.5m
Liabilities
Current Assets 277.7m
Cash & Short-Term Investments 274.4m
Other Current Assets 3.3m
Non-Current Assets 3.7m
PP&E 774k
Other Non-Current Assets 3m
Current Liabilities 5.4m
Accounts Payable 3.4m
Accrued Liabilities 1.7m
Other Current Liabilities 283k
Non-Current Liabilities 3.1m
Other Non-Current Liabilities 3.1m

Balance Sheet
Silverback Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
387
254
211
Cash Equivalents
387
254
211
Short-Term Investments
0
0
64
Other Current Assets
4
7
3
Total Current Assets
391
261
278
PP&E Net
4
7
1
PP&E Gross
4
7
1
Accumulated Depreciation
2
3
0
Long-Term Investments
0
65
0
Other Long-Term Assets
0
0
3
Total Assets
395
N/A
333
-16%
281
-16%
Liabilities
Accounts Payable
3
2
3
Accrued Liabilities
6
13
2
Short-Term Debt
1
0
0
Current Portion of Long-Term Debt
0
0
0
Other Current Liabilities
0
0
0
Total Current Liabilities
10
15
5
Long-Term Debt
0
0
0
Other Liabilities
2
5
3
Total Liabilities
12
N/A
20
+65%
9
-56%
Equity
Common Stock
0
0
0
Retained Earnings
97
186
77
Additional Paid In Capital
480
500
349
Other Equity
0
0
0
Total Equity
383
N/A
314
-18%
273
-13%
Total Liabilities & Equity
395
N/A
333
-16%
281
-16%
Shares Outstanding
Common Shares Outstanding
35
35
94

See Also

Summary
SBTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBTX stock valuation using valuation multiples.
Wall Street Estimates
SBTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.